指南与共识细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

巴基斯坦社区获得性呼吸道感染背景下的抗菌药物耐药性国家数据:抗菌药物敏感性、地方与国际抗生素处方指南、药物可及性与临床结局之间的联系

Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
指南 / 共识 · J Antimicrob Chemother · 2022-01-01

该指南类文章综述了巴基斯坦抗菌药物耐药性(AMR)现状、国家行动计划、抗生素使用与处方情况,以及社区获得性呼吸道感染(CA-RTI)关键病原体(肺炎链球菌和流感嗜血杆菌)的药敏数据可及性。文章指出巴基斯坦抗生素消耗量高、虽有立法禁止非处方购买抗生素但仍可实现,且缺乏本地流行微生物的AMR监测;作者认为采用最新本地社区感染分离株监测数据制定更具本地相关性的指南,可促进更合理的抗生素处方与依从性,从而可能限制AMR发展并改善患者结局。

要点

  • 巴基斯坦已制定国家行动计划应对AMR,但抗生素消耗量高且非处方购买仍可实现。
  • 医疗专业人员管理CA-RTI患者时使用地方和国际抗生素处方指南。
  • 临床微生物学家指出缺乏对本地流行微生物的AMR监测。

核心结论

  • 巴基斯坦正在积极制定应对AMR的举措如国家行动计划,但抗生素消耗量高且虽有立法禁止非处方购买抗生素但仍可实现。
  • 医疗专业人员管理CA-RTI患者时使用地方和国际抗生素处方指南。
  • 临床微生物学家的专家评论指出缺乏对本地流行微生物的AMR监测。
  • 作者认为采用最新本地社区感染分离株监测数据、以更标准化包容性方法制定本地指南,可使管理指南使用对临床医生更具本地相关性,从而为更高水平的适当抗生素处方和改善依从性铺平道路,进而可能限制AMR发展并改善患者临床结局。

研究设计与样本

  • 该文章为指南类文件,由J Antimicrob Chemother发布,识别了巴基斯坦国家AMR举措、抗生素使用与处方情况以及药敏数据可及性。
  • 识别了CA-RTI关键病原体(肺炎链球菌和流感嗜血杆菌)的药敏数据可及性。
  • 综述了当地常用的特定CA-RTI(社区获得性肺炎、急性中耳炎和急性细菌性鼻窦炎)国家和国际抗生素处方指南以及当地抗生素可及性。
  • 征求了当地临床医生和临床微生物学家的见解以对信息进行情境化。

主要发现

  • 巴基斯坦抗生素消耗量高。
  • 虽有立法禁止非处方购买抗生素,但仍可实现非处方购买。
  • 医疗专业人员管理CA-RTI患者时使用地方和国际抗生素处方指南。
  • 临床微生物学家的专家评论指出缺乏对本地流行微生物的AMR监测。

临床怎么用

  • 作者认为采用最新本地社区感染分离株监测数据、以更标准化包容性方法制定本地指南,可使管理指南使用对临床医生更具本地相关性。
  • 作者认为这可为更高水平的适当抗生素处方和改善依从性铺平道路,进而可能限制AMR发展并改善患者临床结局。

局限性

  • 临床微生物学家的专家评论指出缺乏对本地流行微生物的AMR监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action. OBJECTIVES: To review the current situation with respect to AMR in Pakistan and initiatives addressing it. Identifying areas where more information is required will provide a call to action to minimize any further rises in AMR and improve patient outcomes. METHODS: National AMR initiatives, antibiotic use and prescribing in Pakistan, and availability of susceptibility data, in particular for the key community-acquired respiratory tract infection (CA-RTI) pathogens (Streptococcus pneumoniae and Haemophilus influenzae) were identified. National and international antibiotic prescribing guidelines for specific CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) commonly used locally were also reviewed, plus local antibiotic availability. Insights from a local clinician and clinical microbiologist were sought to contextualize this information. CONCLUSIONS: Pakistan is active in developing initiatives to address AMR such as compiling a National Action Plan. However, antibiotic consumption is high and although there is legislation in place prohibiting over-the-counter purchase of antibiotics, this is still possible. Healthcare professionals use local and international antibiotic prescribing guidelines for CA-RTIs when managing patients. As highlighted by the clinical microbiologist's expert comments, surveillance of AMR in locally prevalent microorganisms is lacking. A more standardized inclusive approach in developing local guidelines, using up-to-date local surveillance data of isolates from community-acquired infections, could make management guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve clinical outcomes for patients.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Torumkuney D, Jamil B, Nizamuddin S, et al. Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. J Antimicrob Chemother. 2022. PMID: 36065729. doi:10.1093/jac/dkac213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。